Sara B McMenamin
Biographic Data
| ID | 5544548 |
|---|---|
| NAME | Sara B McMenamin |
| GIVEN NAMES | Sara B |
| FAMILY NAME | McMenamin |
| SIGNATURE | MCMENAMIN S B |
| AFFILIATIONS | University of California San Diego |
| ORCID | 0000-0003-3235-6936 |
| VERIFIED | Yes |
| TOTAL WORKS | 17 |
| TOTAL CITATIONS | 1 |
| AUTHOR COUNT | 17 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2001 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 1 |
Tobacco advertising, cross-over effects, and US adolescent progression from never to current tobacco use
Among adolescents who were receptive to tobacco advertising but had never used tobacco at baseline, there was significant progression to current and daily tobacco use 6.6 years later. The cross-over advertising effect went beyond the particular advertised product and effectively promoted daily nicotine use, particularly among 12-14-year-old adolescents at baseline, with progression to e-cigarettes. Population increases in adolescent progression t…
Improving Implementation of Fertility Preservation Benefit Mandates
In this study, multiple barriers and facilitators were systematically identified to assist in improving implementation of FP benefit mandates. These findings support policies and intervention development for FP patients and clinics, and future legislative and regulatory efforts aimed at increasing timely access to FP insurance benefits
Cannabis use and progression to regular tobacco use among United States youth and young adults: Evidence from the Population Assessment of Tobacco and Health (Path) study, 2017–2021
Among US youth and young adults who had never regularly used tobacco, cannabis use in 2017 was associated with a large increase in current regular tobacco use in 2021
Cigarette smoking decline among US young adults from 2000 to 2019, in relation to state-level cigarette price and tobacco control expenditure
National programmes may have filled a gap in state-level interventions, helping drive down the social acceptability of cigarette smoking among young adults across all states. Additional interventions are needed to assist high-prevalence states to further reduce smoking
Declines in cigarette smoking among US adolescents and young adults: Indications of independence from e-cigarette vaping surge
Since 1997, a large decline in cigarette smoking occurred in the US population under age 24 years, that was independent of the 2017-19 adolescent surge in past 30-day e-cigarette vaping. Further research is needed to assess whether the 2014-15 to 2018-19 increase in exclusive vaping in those aged 18-24 years is a cohort effect from earlier dependence on e-cigarette vaping as adolescents
Effectiveness of e-cigarettes as aids for smoking cessation: Evidence from the Path Study cohort, 2017–2019
Sales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse
Assessment of Health Insurance Benefit Mandates for Fertility Preservation Among 11 US States
In this qualitative assessment of 11 state-level FP benefit mandates, variation that may influence patient access was identified in the design and implementation of the mandates. As clinical stakeholders aim to understand and/or shape these laws and their implementation, key considerations included specificity and flexibility of benefit design to be clinically meaningful, expansion of clinical practice guidelines to inform benefit coverage, inclu…
Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
Vaping products containing cannabidiol (CBD), a cannabis-derived compound used in wellness products and available in all 50 US states, were recently implicated in outbreaks of poisonings. Little is known about the commercial availability of CBD products in vape shops (i.e., stores that sell e-cigarettes). To document the availability and marketing of CBD products in online vape shops, in June 2020, we used the Google Chrome browser without cached…
The Importance of Health Insurance in Addressing Asian American Disparities in Utilization of Clinical Preventive Services: 12-Year Pooled Data from California
Purpose: Previous research has shown that Asian Americans are less likely to receive recommended clinical preventive services especially for cancer compared with non-Hispanic whites. Health insurance expansion has been recommended as a way to increase use of these preventive services. This study examines the extent to which utilization of preventive services by Asians overall and by ethnicity compared with non-Hispanic whites is moderated by heal…
Universal Lead Screening Requirement: A California Case Study
Objectives. To estimate potential impacts of California Assembly Bill (AB) 1316: a requirement for universal screening and insurance coverage for child blood lead testing. Methods. In April 2017 the California Health Benefits Review Program (Oakland, CA) analyzed AB 1316 for the California legislature, including a systematic review of lead screening effectiveness, commercial insurer surveys regarding screening coverage, and actuarial utilization …
McMenamin et al. Respond
AffiliationsSara B. McMenamin is with the Department of Family Medicine and Public Health, University of California, San Diego. Sarah P. Hiller is with the Department of Medicine, University of California, San Diego. Erin Shigekawa is with the California Health Benefits Review Program, Berkeley. Riti Shimkhada is with the Fielding School of Public Health, University of California, Los Angeles
Addressing discriminatory benefit design for people living with HIV: A California case study
Concern is growing in the United States regarding the potential for health insurance benefit designs to discriminate against persons living with HIV as research demonstrates that such practices are occurring. A recent complaint filed against health insurers in seven states alleges that some health insurance companies have been using benefit designs that discourage enrollment of people living with HIV either by not covering essential HIV medicatio…
Adoption of System Strategies for Tobacco Cessation by State Medicaid Programs
BACKGROUND: The Public Health Service's Clinical Practice Guideline for treating tobacco dependence recommends 6 system-wide strategies for health administrators, insurers, and purchasers to support tobacco cessation. METHODS: A 24-question survey was sent to each state Medicaid program office in the fall of 2005, including questions to assess whether each state Medicaid program adopted 4 of the 6 system strategies most relevant to Medicaid contr…
The Costs and Effectiveness of Different Benefit Designs for Treating Tobacco Dependence: Results from a Randomized Trial
This research estimated the costs and effectiveness of three different benefit designs for treating tobacco dependence: drugs only (nicotine replacement therapy patch, nasal spray, inhaler, and Zyban); drugs and counseling (drugs and proactive telephone counseling); and drugs if counseling (drugs conditional on enrollment in counseling). A sample of 393 adult smokers enrolled in a California preferred provider organization was randomly assigned t…
Support for Smoking Cessation Interventions in Physician Organizations: Results From a National Study
OBJECTIVES: To document the extent to which physician organizations, defined as medical groups and independent practice associations, are providing support for smoking cessation interventions and to identify external incentives and organizational characteristics associated with this support. METHODS: This research uses data from the National Study of Physician Organizations and the Management of Chronic Illness, conducted by the University of Cal…
Variations in treatment benefits influence smoking cessation: Results of a randomised controlled trial
Full coverage of a tobacco dependence treatment benefit implemented in two IPA model HMOs in California has been shown to be an effective and relatively low cost strategy for significantly increasing quit rates, quit attempts, and use of nicotine gum and patch in adult smokers
Differences in the Kinds of Problems Consumers Report in Staff/Group Health Maintenance Organizations, Independent Practice Association/Network Health Maintenance Organizations, and Preferred Provider…
BACKGROUND: Little is known about the extent to which consumers have specific problems with their managed care organizations (MCOs) or whether these problems differ by type of MCO. OBJECTIVE: To estimate the prevalence at which consumers in managed care report specific problems and to assess whether rates in preferred provider organizations (PPOs), independent practice association (IPA)/network health maintenance organizations (HMOs), and staff/g…
Universal Lead Screening Requirement: A California Case Study
Objectives. To estimate potential impacts of California Assembly Bill (AB) 1316: a requirement for universal screening and insurance coverage for child blood lead testing. Methods. In April 2017 the California Health Benefits Review Program (Oakland, CA) analyzed AB 1316 for the California legislature, including a systematic review of lead screening effectiveness, commercial insurer surveys regarding screening coverage, and actuarial utilization …
Variations in treatment benefits influence smoking cessation: Results of a randomised controlled trial
Full coverage of a tobacco dependence treatment benefit implemented in two IPA model HMOs in California has been shown to be an effective and relatively low cost strategy for significantly increasing quit rates, quit attempts, and use of nicotine gum and patch in adult smokers
Differences in the Kinds of Problems Consumers Report in Staff/Group Health Maintenance Organizations, Independent Practice Association/Network Health Maintenance Organizations, and Preferred Provider…
BACKGROUND: Little is known about the extent to which consumers have specific problems with their managed care organizations (MCOs) or whether these problems differ by type of MCO. OBJECTIVE: To estimate the prevalence at which consumers in managed care report specific problems and to assess whether rates in preferred provider organizations (PPOs), independent practice association (IPA)/network health maintenance organizations (HMOs), and staff/g…
Support for Smoking Cessation Interventions in Physician Organizations: Results From a National Study
OBJECTIVES: To document the extent to which physician organizations, defined as medical groups and independent practice associations, are providing support for smoking cessation interventions and to identify external incentives and organizational characteristics associated with this support. METHODS: This research uses data from the National Study of Physician Organizations and the Management of Chronic Illness, conducted by the University of Cal…
The Costs and Effectiveness of Different Benefit Designs for Treating Tobacco Dependence: Results from a Randomized Trial
This research estimated the costs and effectiveness of three different benefit designs for treating tobacco dependence: drugs only (nicotine replacement therapy patch, nasal spray, inhaler, and Zyban); drugs and counseling (drugs and proactive telephone counseling); and drugs if counseling (drugs conditional on enrollment in counseling). A sample of 393 adult smokers enrolled in a California preferred provider organization was randomly assigned t…
Adoption of System Strategies for Tobacco Cessation by State Medicaid Programs
BACKGROUND: The Public Health Service's Clinical Practice Guideline for treating tobacco dependence recommends 6 system-wide strategies for health administrators, insurers, and purchasers to support tobacco cessation. METHODS: A 24-question survey was sent to each state Medicaid program office in the fall of 2005, including questions to assess whether each state Medicaid program adopted 4 of the 6 system strategies most relevant to Medicaid contr…
Addressing discriminatory benefit design for people living with HIV: A California case study
Concern is growing in the United States regarding the potential for health insurance benefit designs to discriminate against persons living with HIV as research demonstrates that such practices are occurring. A recent complaint filed against health insurers in seven states alleges that some health insurance companies have been using benefit designs that discourage enrollment of people living with HIV either by not covering essential HIV medicatio…
Universal Lead Screening Requirement: A California Case Study
Objectives. To estimate potential impacts of California Assembly Bill (AB) 1316: a requirement for universal screening and insurance coverage for child blood lead testing. Methods. In April 2017 the California Health Benefits Review Program (Oakland, CA) analyzed AB 1316 for the California legislature, including a systematic review of lead screening effectiveness, commercial insurer surveys regarding screening coverage, and actuarial utilization …
McMenamin et al. Respond
AffiliationsSara B. McMenamin is with the Department of Family Medicine and Public Health, University of California, San Diego. Sarah P. Hiller is with the Department of Medicine, University of California, San Diego. Erin Shigekawa is with the California Health Benefits Review Program, Berkeley. Riti Shimkhada is with the Fielding School of Public Health, University of California, Los Angeles
The Importance of Health Insurance in Addressing Asian American Disparities in Utilization of Clinical Preventive Services: 12-Year Pooled Data from California
Purpose: Previous research has shown that Asian Americans are less likely to receive recommended clinical preventive services especially for cancer compared with non-Hispanic whites. Health insurance expansion has been recommended as a way to increase use of these preventive services. This study examines the extent to which utilization of preventive services by Asians overall and by ethnicity compared with non-Hispanic whites is moderated by heal…
Assessment of Health Insurance Benefit Mandates for Fertility Preservation Among 11 US States
In this qualitative assessment of 11 state-level FP benefit mandates, variation that may influence patient access was identified in the design and implementation of the mandates. As clinical stakeholders aim to understand and/or shape these laws and their implementation, key considerations included specificity and flexibility of benefit design to be clinically meaningful, expansion of clinical practice guidelines to inform benefit coverage, inclu…
Availability and Promotion of Cannabidiol (CBD) Products in Online Vape Shops
Vaping products containing cannabidiol (CBD), a cannabis-derived compound used in wellness products and available in all 50 US states, were recently implicated in outbreaks of poisonings. Little is known about the commercial availability of CBD products in vape shops (i.e., stores that sell e-cigarettes). To document the availability and marketing of CBD products in online vape shops, in June 2020, we used the Google Chrome browser without cached…
Effectiveness of e-cigarettes as aids for smoking cessation: Evidence from the Path Study cohort, 2017–2019
Sales increases in high nicotine e-cigarettes in 2017 did not translate to more smokers using these e-cigarettes to quit smoking. On average, using e-cigarettes for cessation in 2017 did not improve successful quitting or prevent relapse
Declines in cigarette smoking among US adolescents and young adults: Indications of independence from e-cigarette vaping surge
Since 1997, a large decline in cigarette smoking occurred in the US population under age 24 years, that was independent of the 2017-19 adolescent surge in past 30-day e-cigarette vaping. Further research is needed to assess whether the 2014-15 to 2018-19 increase in exclusive vaping in those aged 18-24 years is a cohort effect from earlier dependence on e-cigarette vaping as adolescents
Cigarette smoking decline among US young adults from 2000 to 2019, in relation to state-level cigarette price and tobacco control expenditure
National programmes may have filled a gap in state-level interventions, helping drive down the social acceptability of cigarette smoking among young adults across all states. Additional interventions are needed to assist high-prevalence states to further reduce smoking
Improving Implementation of Fertility Preservation Benefit Mandates
In this study, multiple barriers and facilitators were systematically identified to assist in improving implementation of FP benefit mandates. These findings support policies and intervention development for FP patients and clinics, and future legislative and regulatory efforts aimed at increasing timely access to FP insurance benefits
Cannabis use and progression to regular tobacco use among United States youth and young adults: Evidence from the Population Assessment of Tobacco and Health (Path) study, 2017–2021
Among US youth and young adults who had never regularly used tobacco, cannabis use in 2017 was associated with a large increase in current regular tobacco use in 2021
Tobacco advertising, cross-over effects, and US adolescent progression from never to current tobacco use
Among adolescents who were receptive to tobacco advertising but had never used tobacco at baseline, there was significant progression to current and daily tobacco use 6.6 years later. The cross-over advertising effect went beyond the particular advertised product and effectively promoted daily nicotine use, particularly among 12-14-year-old adolescents at baseline, with progression to e-cigarettes. Population increases in adolescent progression t…
Medicine (13 works) · Smoking Behavior and Cessation (9 works) · Environmental health (8 works) · Business (7 works) · Family medicine (7 works) · Population (7 works) · Health care (6 works) · Public health (6 works) · Internal Medicine (5 works) · Political science (5 works)